Adding Olfactory Cleft Platelet-Rich Plasma to Intranasal Steroids and Olfactory Training for Persistent Post-Viral Smell Loss: A Three-Arm Randomized Controlled Trial

Authors

  • Osama Awaad Ali Department of Surgery, College of Medicine, University of Wasit, Kut, Iraq

Keywords:

post-viral olfactory dysfunction, anosmia, hyposmia, olfactory training, platelet-rich plasma, mometasone, Sniffin’ Sticks, randomized controlled trial

Abstract

Background: Smell loss after an upper respiratory viral infection often persists for months, and current treatments are only partly effective. Olfactory training is the recommended first-line treatment, intranasal corticosteroids are widely prescribed, and platelet-rich plasma (PRP) injected into the olfactory cleft has emerged as a possible regenerative option. Few randomized trials have compared these approaches or tested them in combination.

Objective: To assess the incremental benefit of adding olfactory training, and then olfactory cleft PRP, to intranasal corticosteroids in adults with persistent post-viral olfactory dysfunction (PVOD).

Methods: In this single-centre, assessor-blinded randomized controlled trial, 135 adults with PVOD lasting more than 3 months were randomized 1:1:1 to mometasone nasal spray alone, mometasone plus olfactory training, or mometasone plus olfactory training plus two endoscopic PRP injections into the olfactory cleft (n = 45 per arm). The primary outcome was the change in Sniffin’ Sticks threshold–discrimination–identification (TDI) score from baseline to 6 months; self-rated smell on a visual analogue scale (VAS) was the secondary outcome. Patients were assessed at baseline and at 1, 3 and 6 months (ClinicalTrials.gov NCT06184920).

Results: The arms were balanced at baseline (mean TDI approximately 17), and 129 of the 135 randomized patients completed the 6-month assessment. Mean 6-month TDI gains were 5.25, 10.30 and 16.45 points with steroids alone, steroids plus training, and steroids plus training plus PRP, respectively. The adjusted difference was 5.05 points (95% CI 3.42 to 6.68) for training added to steroids and 6.15 points (95% CI 4.48 to 7.82) for PRP added to steroids and training (both p < 0.001). Six-month VAS scores followed the same order (5.05, 7.11 and 8.20). Adverse events were mild and transient, and no infections or serious adverse events occurred.

Conclusions: Adding olfactory training, and then olfactory cleft PRP, to intranasal steroids produced stepwise improvements in measured and self-rated smell over 6 months. Because patients were not blinded and there was no sham-injection arm, the size of the PRP effect needs confirmation in sham-controlled trials.

Downloads

Published

2026-11-15

Issue

Section

Articles

How to Cite

1.
Osama Awaad Ali. Adding Olfactory Cleft Platelet-Rich Plasma to Intranasal Steroids and Olfactory Training for Persistent Post-Viral Smell Loss: A Three-Arm Randomized Controlled Trial. Sawa Med. J. [Internet]. 2026 Nov. 15 [cited 2026 Nov. 17];2(4):674-85. Available from: https://smj.sawauniversity.edu.iq/article/view/889